Simplifying Global Compliance
Synthes Executives Plead Guilty, Company Faces Court Date
Devices & Diagnostics Letter
Three of four Synthes officials charged in connection with off-label promotion and illegal clinical trials of a bone void filler pleaded guilty last week to a misdemeanor of introducing misbranded Norian XR into interstate commerce.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing